Results 11 to 20 of about 32,822 (166)
, 2022 Antiplatelet agents have been utilized to enhance outcomes in patients with acute coronary syndrome for decades and are increasingly valued for their antithrombotic as well as anti-inflammatory characteristics. Dual antiplatelet therapy (DAPT) is a combination of aspirin and a P2Y12 inhibitor.
Edidiong Orok +2 more
openaire +1 more source
Российский кардиологический журнал, 2020 The feasibility of dual antiplatelet therapy as early as possible in patients with ST-segment elevation acute coronary syndrome, where percutaneous coronary intervention is recommended, has been proven: it improves treatment outcomes by reducing the risk
T. S. Golovina +2 more
doaj +1 more source
Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation. [PDF]
PLoS ONE, 2016 Bleeding is a frequent complication in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO). An indication for dual antiplatelet therapy due to coronary stent implantation is present in a considerable number of these patients.
Dawid L Staudacher +5 more
doaj +1 more source
Український журнал серцево-судинної хірургії, 2023 The aim. To analyze changes in the activity of the platelet link of hemocoagulation in patients with chronic coronary syndrome before and after percutaneous coronary intervention (PCI) against the background of prior antiplatelet therapy.
Nataliia I. Kozachyshyn +2 more
doaj +1 more source
Clinical presentations, antiplatelet strategies and prognosis of patients with stent thrombosis: an observational study of 140 patients. [PDF]
PLoS ONE, 2012 BACKGROUND: Until now there has been scarce evidence regarding an optimal antiplatelet strategy and clinical outcomes for patients who had suffered from stent thrombosis (ST).
Ya-Ling Han +12 more
doaj +1 more source
Analysis of Dual Antiplatelet Therapy
Journal of the American College of Cardiology, 2015 In a post-hoc analysis, Yeh et al. [(1)][1] provide evidence that dual-antiplatelet therapy with thienopyridine and aspirin, for 30 (vs. 12) months after coronary stenting, had beneficial effects regardless of whether patients had acute myocardial infarction (MI) or less acute presentations ...
Ganeshan, Raj +2 more
openaire +2 more sources
Dual Antiplatelet Therapy for Heart Disease [PDF]
Circulation, 2014 Within the body, the heart pumps blood through paths called vessels so that all of the body’s organs get the oxygen and nutrients they need to function properly. The blood itself contains many components in addition to oxygen and nutrients, including tiny plate-shaped cell fragments fittingly called platelets.
Edward T, Carreras, Jessica L, Mega
openaire +2 more sources
Journal of Investigative Medicine High Impact Case Reports, 2021 Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percutaneous coronary intervention for patients who are at a high bleeding
Taylor C. Remillard MD, Don C. Rockey MD
doaj +1 more source
PLoS ONE, 2020 ObjectivesAntiplatelet therapy following peripheral arterial endovascular intervention lacks high quality evidence to guide practice. The aim of this study was to assess the effect of three months of dual antiplatelet therapy on amputation-free survival ...
Natasha Chinai +8 more
doaj +1 more source
BMC Neurology, 2020 Background New evidence on the efficacy and safety of dual antiplatelet therapy for secondary stroke prevention have been realized in the recent years. An updated meta analysis was done to determine the effect of the various dual antiplatelets vs aspirin
Christessa Emille Que Albay +2 more
doaj +1 more source